ASSESSMENT OF 10-YEAR PROBABILITY OF OSTEOPOROTIC FRACTURES WITH THE RUSSIAN MODEL OF FRAX® IN A POPULATION-BASED SAMPLE 5 REGIONS OF RUSSIA
https://doi.org/10.21518/2079-701X-2017-0-103-107
Abstract
Osteoporosis is a significant health problem due to high frequency of occurrence of fractures at a low traumatic impact. Densitometric examination does not allow to fully identify individuals with an increased risk of osteoporotic fractures, because bone mineral density is one of the components of the fracture cause in osteoporosis. Among the alternative methods of predicting the risk of fractures the algorithm FRAX® has become widely used in the world, which can be used to calculate 10-year probability of major osteoporotic fracture based on clinical risk factors that showed an independent effect on BMD and/ or bone strength. A survey in 5 regions of Russia showed that 31% of women and 4% of men had values of FRAX® above the threshold of therapeutic intervention and as a result, needed the indication of antiosteoporotic therapy. The greatest need for treatment and preventive measures as determined using the algorithm FRAX® was detected in women in the Siberian, Uralian and Central region and in men – in the North-Western and Uralian Federal districts.
About the Authors
O. A. NikitinskayaRussian Federation
PhD in medicine
N. V. Toroptsova
Russian Federation
MD, Prof.
References
1. Wainwright SA, Marshall LM, Ensrud KE, Cauley JA, Black DM, Hillier TA, et al. Hip fracture in women without osteoporosis. J Clin Endocrinol Metab, 2005, 90(5): 2787-93.
2. Kanis JA, Harvey NC, Cooper C, Johansson H, Odén A, McCloskey EV. A systematic review of intervention thresholds based on FRAX: A report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos, 2016, 11(1): 25. doi: 10.1007/s11657-016-0278-z.
3. Kanis JA. McCloskey EV, Johansson H, Cooper C, Rizzoli R, Reginster J-Y. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int, 2013, 24: 23-57. DOI 10.1007/s00198-012-2074-y.
4. Kanis JA, Hans D, Cooper C, Baim S, Bilezikian JP, Binkley N et al. Interpretation and use of FRAX in clinical practice. Osteoporos Int, 2011, 22(9): 2395-2411. DOI 10.1007/s00198-011-1713-z.
5. Торопцова Н.В., Баранова И.А., Лесняк О.М. Рекомендации по применению российской модели FRAX® для определения 10-летней вероятности остеопоротических переломов. Фарматека, 2016, Остеопороз/Ревматология: 10-14.
6. Лесняк О.М., Ершова О.Б., Белова К.Ю., Гладкова Е.Н., Синицына О.С., Ганерт О.А. и др. Эпидемиология остеопоротических переломов в российской Федерации, и Российская модель FRAX. Остеопороз и остеопатии, 2014, 3: 3-8.
7. Скрипникова И.А., Гурьев А.В., Шальнова С.А., Деев А.Д., Артамонова Г.В., Гатагонова Т.М. и др. Распространенность основных факторов риска остеопороза и оценка 10-летней вероятности переломов с помощью FRAX® у городского населения различных климатогеографических ареалов РФ. Остеопороз и остеопатии, 2016, 2: 30-31.
8. Ершова О.Б., Синицына О.С., Белова К.Ю., Дегтярев А.А., Ганерт О.А., Романова М. А. и др. Результаты анализа факторов риска и абсолютного риска переломов (FRAX) у мужчин с переломами проксимального отдела бедра. Остеопороз и остеопатии, 2013, 1: 3-6.
Review
For citations:
Nikitinskaya OA, Toroptsova NV. ASSESSMENT OF 10-YEAR PROBABILITY OF OSTEOPOROTIC FRACTURES WITH THE RUSSIAN MODEL OF FRAX® IN A POPULATION-BASED SAMPLE 5 REGIONS OF RUSSIA. Meditsinskiy sovet = Medical Council. 2017;(1S):103-107. (In Russ.) https://doi.org/10.21518/2079-701X-2017-0-103-107